1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)


SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

Cell lines tested with navitoclax:sorafenib (1:1 mol/mol)

835 cell lines have been tested with this compound, using data from 1 dataset(s).
CAS-1 central nervous system CTRPv21
KPL-1 breast CTRPv21
MKN1 stomach CTRPv21
BFTC-905 urinary tract CTRPv21
BFTC-909 urinary tract CTRPv21
HuCCT1 biliary tract CTRPv21
NMC-G1 central nervous system CTRPv21
ALL-SIL haematopoietic and lymphoid tissue CTRPv21
HDQ-P1 breast CTRPv21
SNU-245 biliary tract CTRPv21
Download CSV

Tissues tested with navitoclax:sorafenib (1:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
salivary glandCTRPv21
biliary tractCTRPv26
autonomic gangliaCTRPv213
soft tissueCTRPv218
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP33 CTRPv2 AAC 0.33 2e-20
mRNA TUBA1A CTRPv2 AAC 0.3 2e-14
mRNA RP11-729L2.2 CTRPv2 AAC 0.29 2e-14
mRNA SMAD4 CTRPv2 AAC 0.28 2e-14
mRNA GOLGA8M CTRPv2 AAC 0.26 2e-14
mRNA CELF4 CTRPv2 AAC 0.28 2e-14
mRNA PRR36 CTRPv2 AAC 0.28 6e-14
mRNA HDHD2 CTRPv2 AAC 0.28 7e-14
mRNA TIFAB CTRPv2 AAC 0.25 8e-14
mRNA CRMP1 CTRPv2 AAC 0.3 9e-14
Download CSV